The challenges of blinding in clinical trial – and how we make it easier and more effective
Blinding is an essential ingredient in a randomised controlled trial (RCT), ensuring that the placebo and the Investigational Medicinal Product […]
2 January 2026
Bridging the gap between chemistry, manufacturing, and control (CMC) data and the regulator, for right first time trial approval
The quicker your clinical trial can be approved by the regulator, the quicker you can progress your study and proceed
Trial medication about to expire? Here are the options
Investigational Medicinal Products (IMPs) that expire before last patient, last visit are undoubtedly a nightmare scenario for any Sponsor. In
Succeed faster to get early-phase studies through milestones quicker
We’ve posted elsewhere about the many data challenges involved in early-phase clinical trial approval, and how we at Eramol adopt